These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 25328905)

  • 1. μ-Opioid activation in the midbrain during migraine allodynia - brief report II.
    Nascimento TD; DosSantos MF; Lucas S; van Holsbeeck H; DeBoer M; Maslowski E; Love T; Martikainen IK; Koeppe RA; Smith YR; Zubieta JK; DaSilva AF
    Ann Clin Transl Neurol; 2014 Jun; 1(6):445-50. PubMed ID: 25328905
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of μ-Opioid Activation in the Prefrontal Cortex with Spontaneous Migraine Attacks - Brief Report I.
    DaSilva AF; Nascimento TD; DosSantos MF; Lucas S; van HolsbeecK H; DeBoer M; Maslowski E; Love T; Martikainen IK; Koeppe RA; Smith YR; Zubieta JK
    Ann Clin Transl Neurol; 2014 Jun; 1(6):439-444. PubMed ID: 25072055
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of chronic migraine attacks and their severity on the endogenous μ-opioid neurotransmission in the limbic system.
    Jassar H; Nascimento TD; Kaciroti N; DosSantos MF; Danciu T; Koeppe RA; Smith YR; Bigal ME; Porreca F; Casey KL; Zubieta JK; DaSilva AF
    Neuroimage Clin; 2019; 23():101905. PubMed ID: 31279240
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 3D-neuronavigation in vivo through a patient's brain during a spontaneous migraine headache.
    DaSilva AF; Nascimento TD; Love T; DosSantos MF; Martikainen IK; Cummiford CM; DeBoer M; Lucas SR; Bender MA; Koeppe RA; Hall T; Petty S; Maslowski E; Smith YR; Zubieta JK
    J Vis Exp; 2014 Jun; (88):. PubMed ID: 24962460
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Classifying migraine using PET compressive big data analytics of brain's
    Marino S; Jassar H; Kim DJ; Lim M; Nascimento TD; Dinov ID; Koeppe RA; DaSilva AF
    Front Pharmacol; 2023; 14():1173596. PubMed ID: 37383727
    [No Abstract]   [Full Text] [Related]  

  • 6. Allodynia and descending pain modulation in migraine: a resting state functional connectivity analysis.
    Schwedt TJ; Larson-Prior L; Coalson RS; Nolan T; Mar S; Ances BM; Benzinger T; Schlaggar BL
    Pain Med; 2014 Jan; 15(1):154-65. PubMed ID: 24165094
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immediate effects of tDCS on the μ-opioid system of a chronic pain patient.
    DosSantos MF; Love TM; Martikainen IK; Nascimento TD; Fregni F; Cummiford C; Deboer MD; Zubieta JK; Dasilva AF
    Front Psychiatry; 2012; 3():93. PubMed ID: 23130002
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Triggers in allodynic and non-allodynic migraineurs. A clinic setting study.
    Baldacci F; Vedovello M; Ulivi M; Vergallo A; Poletti M; Borelli P; Cipriani G; Nuti A; Bonuccelli U
    Headache; 2013 Jan; 53(1):152-160. PubMed ID: 23278553
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ictal and interictal brain activation in episodic migraine: Neural basis for extent of allodynia.
    Maleki N; Szabo E; Becerra L; Moulton E; Scrivani SJ; Burstein R; Borsook D
    PLoS One; 2021; 16(1):e0244320. PubMed ID: 33395413
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reduced basal ganglia μ-opioid receptor availability in trigeminal neuropathic pain: a pilot study.
    DosSantos MF; Martikainen IK; Nascimento TD; Love TM; Deboer MD; Maslowski EC; Monteiro AA; Vincent MB; Zubieta JK; DaSilva AF
    Mol Pain; 2012 Sep; 8():74. PubMed ID: 23006894
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Terminating migraine with allodynia and ongoing central sensitization using parenteral administration of COX1/COX2 inhibitors.
    Jakubowski M; Levy D; Goor-Aryeh I; Collins B; Bajwa Z; Burstein R
    Headache; 2005; 45(7):850-61. PubMed ID: 15985101
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Changes in Brainstem Pain Modulation Circuitry Function over the Migraine Cycle.
    Marciszewski KK; Meylakh N; Di Pietro F; Mills EP; Macefield VG; Macey PM; Henderson LA
    J Neurosci; 2018 Dec; 38(49):10479-10488. PubMed ID: 30341182
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interictal alterations of the trigeminal somatosensory pathway and periaqueductal gray matter in migraine.
    DaSilva AF; Granziera C; Tuch DS; Snyder J; Vincent M; Hadjikhani N
    Neuroreport; 2007 Mar; 18(4):301-5. PubMed ID: 17435592
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clarification of developing and established clinical allodynia and pain-free outcomes.
    Landy SH; McGinnis JE; McDonald SA
    Headache; 2007 Feb; 47(2):247-52. PubMed ID: 17300364
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Generalized Pain Sensitization and Endogenous Oxytocin in Individuals With Symptoms of Migraine: A Cross-Sectional Study.
    You DS; Haney R; Albu S; Meagher MW
    Headache; 2018 Jan; 58(1):62-77. PubMed ID: 29094347
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Does pain sensitivity change by migraine phase? A blinded longitudinal study.
    Uglem M; Omland PM; Nilsen KB; Tronvik E; Stovner LJ; Hagen K; Linde M; Sand T
    Cephalalgia; 2017 Dec; 37(14):1337-1349. PubMed ID: 27919023
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Migraine and the Mu-opioidergic system-Can we directly modulate it? Evidence from neuroimaging studies.
    DaSilva AF; Nascimento TD; DosSantos MF; Zubieta JK
    Curr Pain Headache Rep; 2014 Jul; 18(7):429. PubMed ID: 24842566
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cardiovascular effects of microinjections of opioid agonists into the 'Depressor Region' of the ventrolateral periaqueductal gray region.
    Keay KA; Crowfoot LJ; Floyd NS; Henderson LA; Christie MJ; Bandler R
    Brain Res; 1997 Jul; 762(1-2):61-71. PubMed ID: 9262159
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Allodynia in migraine: frequent random association or unavoidable consequence?
    Lovati C; D'Amico D; Bertora P
    Expert Rev Neurother; 2009 Mar; 9(3):395-408. PubMed ID: 19271948
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of buprenorphine maintenance dose on mu-opioid receptor availability, plasma concentrations, and antagonist blockade in heroin-dependent volunteers.
    Greenwald MK; Johanson CE; Moody DE; Woods JH; Kilbourn MR; Koeppe RA; Schuster CR; Zubieta JK
    Neuropsychopharmacology; 2003 Nov; 28(11):2000-9. PubMed ID: 12902992
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.